Bright Minds Biosciences Inc.DRUGNASDAQ

Revenue (LTM)

Net Income (LTM)

$-12M

-336.5% YoY

Free Cash Flow

$-9M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	0
Operating Income	-9	-15↓73.7%	-7↑50.7%	-3↑61.8%	-14↓393.8%
Net Income	-9	-15↓73.0%	-7↑50.7%	-3↑62.0%	-12↓336.5%
EBITDA	0	-15	-7↑51.1%	-3↑62.4%	-14↓404.1%
EPS Diluted	-4.74	-6.15↓29.7%	-1.98↑67.8%	-0.65↑67.2%	-1.78↓173.8%

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Cash & Equivalents	20	12↓41.2%	7↓42.0%	6↓15.2%	83↑1349.4%
Total Current Assets	20	12↓40.4%	7↓43.0%	6↓12.1%	84↑1308.2%
Total Assets	20	12↓39.7%	7↓43.1%	6↓11.3%	84↑1282.9%
Total Current Liabilities	1	1↑130.6%	0↓80.9%	1↑88.2%	2↑341.7%
Total Liabilities	1	2↑141.9%	0↓81.8%	1↑102.3%	2↑318.2%
Total Equity	19	11↓45.7%	7↓37.4%	6↓16.1%	82↑1381.9%
Total Debt	0	0	0↓47.4%	0↑61.7%	0↑5.7%
Net Debt	-20	-11↑41.9%	-7↑41.9%	-6↑16.1%	-83↓1378.0%

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Operating Cash Flow	-7	-14↓85.6%	-7↑48.3%	-2↑73.7%	-9↓369.8%
Capital Expenditure	0	0	0	0	0
Free Cash Flow	-7	-14↓85.6%	-7↑48.3%	-2↑73.7%	-9↓369.8%
Stock-Based Comp	1	1↓0.6%	1↑31.7%	1↓27.1%	3↑279.0%
Net Change in Cash	19	-8↓142.9%	-5↑40.0%	-1↑78.9%	77↑7609.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance